Management of Clostridium difficile infection and other antibiotic-associated diarrhoeas

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 11, 1996, Pages 1054-1061

  Bartlett, John G ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antibiotic associated diarrhoea; Clostridium difficile toxin; Nosocomial diarrhoea; Pseudomembranous colitis

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BACITRACIN; CEPHALOSPORIN; CLARITHROMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; COLESTYRAMINE; COTRIMOXAZOLE; ERYTHROMYCIN; MACROLIDE; METRONIDAZOLE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; DIAGNOSTIC TEST; DIARRHEA; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; HOSPITAL INFECTION; HUMAN; HYPOALBUMINEMIA; INTESTINE INFECTION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSEUDOMEMBRANOUS COLITIS; REVIEW; TOXIC MEGACOLON;

EID: 0029823760     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199611000-00005     Document Type: Review

References (86)

1. Bartlett JC, Chang TW, Gurwith M, et al.: Antibiotic-associated pseudomembranous colitis due to toxin producing clostridia. N Engl J Med 1978, 298:531.
2. Anand A, Bashey B, Mir T, Glatt AE: Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. Am J Gastroenterol 1994, 89:519.
3. Swartzberg JE, Maresca RM, Remington JW: Gastrointestinal side effects associated with clindamycin. Arch Intern Med 1976, 136:876.
4. Neu HC, Prince A, Neu CO, Garvey GJ: Incidence of diarrhea and colitis associated with clindamycin therapy. J Infect Dis 1977, 135:S120.
5. Gilbert DN: Aspects of the safety profile of oral antimicrobial agents. Infect Dis Clin Pracrt 1995, 4(suppl. 2):S103.
6. Viscidi R, Willey S, Bartlett JG: Isolation rates and toxigenic potential for Clostridium difficile isolates from various patient populations. Gastroenterology 1981, 81:5.
7. Borriello SP, Larson HE, Welch AR: Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet 1984, i:305.
8. Sun M: In search of salmonella's smoking gun. Science 1984, 226:30.
9. Danna PL, Urban D, Bellin E, Rahall JJ: Role of Candida in pathogenesis of antibiotic-associated diarrhea in elderly inpatients. Lancet 1991, 337:511.
10. Fekety R, Shah AB: Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993, 269:71.
11. Anand A, Glatt AE: Clostridium difficile infection associated with antineoplastic chemotherapy: A review. Clin Infect Dis 1993, 17:109.
12. Kelly C, Pothoulakis C, LaMont JT: Clostridium difficile colitis. N Engl J Med 1994, 330:257.
13. Bartlett JG: Clostridium difficile: clinical considerations. Rev Infect Dis 1990, 12:S244.
14. Tedesco FJ, Barton RW, Alpers DH: Clindamycin-associated colitis: a prospective study. Ann Intern Med 1974, 81:429.
15. Manabe YC, Vinetz JM, Moore RD, et al.: Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med 1995, 123:835.
16. Bartlett JG: Antibiotic-associated diarrhea. Clin Infect Dis 1992, 15:573.
17. Mogg GM, Keighley M, Burdon D, et al.: Antibiotic-associated colitis - a review of 66 cases. Br J Surg 1979, 66:738.
18. Keighley MRB: Antibiotic-associated pseudomembranous colitis: pathogenesis and management. Drugs 1990, 20:49.
19. Cooper GS, Lederman MM, Salata RA: A predictive model to identify Clostridium difficile toxin in hospitalized patients with diarrhea. Am J Gastroenterol 1996, 91:80.
20. Tedesco FJ, Anderson CB, Ballinger WF: Drug-induced colitis mimicking an acute surgical condition of the abdomen. Arch Surg 1975, 100:481.
21. Yong WH, Mattia AR, Ferraro MJ: Comparison of fecal lactoferrin latex agglutination assay and methylene blue microscopy for detection of fecal leukocytes in Clostridium difficile-associated disease. J Clin Microbiol 1994, 32:1360.
22. Schleupner MA, Garner DC, Sosnowski KM, et al.: Concurrence of Clostridium difficile toxin A enzyme-linked immunosorbent assay, fecal lactoferrin assay, and clinical criteria with C. difficile cytotoxin titer in two patient cohorts. J Clin Microbiol 1995, 33:1755.
23. Putterman C, Rubinow A: Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum 1993, 22:420.
24. Merel LA, Osborn TG: Clostridium difficile-associated reactive arthritis in an HLA-B27 positive female: report and literature review. J Rheumatol 1989, 16:133.
25. McFarland LV, Stamm WE: Nosocomial Clostridium difficile infections. N Engl J Med 1989, 321:190.
26. Taylor NS, Thorne G, Bartlelt JG: Comparison of two toxins produced by Clostridium difficile. Infect Immun 1981, 34:1036.
27. Sullivan NM, Pettett S, Wilkins TD: Purification and characterization of toxins A and B of Clostridium difficile, Infect Immun 1982, 35:1032.
28. Borriello SC, Wren BW, Hyde S, et al.: Molecular, immunological, and biological characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile, Infect Immun 1992, 60:4192.
29. Wren BW, Heard S, Tabaqchali S: Association between production of toxins A and B and types of Clostridium difficile. J Clin Pathol 1987, 40:1297.
30. Burakoff R, Zhao L, Celifarco AJ, et al.: Effects of purified Clostridium difficile toxin A on rabbit distal colon. Gastroenterology 1995, 190(2):348.
31. Fluit AC, Wolfhagen MJHM, Verdonk GPHT, et al.: Nontoxigenic strains of Clostridium difficile lack the genes for both toxin A and toxin B. J Clin Microbiol 1991, 29:2666.
32. Riegler M, Sedivy R, Pothoulakis C, et al.: Clostridium difficile toxin B is more potent that toxin A in damaging human colonie epithelium in vitro. J Clin Invest 1995, 95:2004.
33. Aronsson B, Mollby R, Nord, CE: Antimicrobial agents and Clostridium difficile in acute disease: epidemiological data from Sweden, 1980-1982. J Infect Dis 1985, 151:476.
34. Viscidi R, Laughon BE, Yolken R, et al.: Serum antibody response to toxins A and B of Clostridium difficile. J Infect Dis 1983, 148:93.
35. Finney JMT: Gastro-enterostomy for cicatrizing ulcer of the pylorus. Bull Johns Hopkins Hosp 1893, 4:53.
36. Hummel RP, Altemeier WA, Hill EO: latrogenic staphylococcal enterocolitis. Ann Surg 1964, 160:551.
37. Stanley RJ, Melson GL, Tedesco FJ, Saylor JL : Plain-film findings in severe pseudomembranous colitis. Radiology 1976, 118:7.
38. Rubesin SE, Levine MS, Glick SN, et al.: Pseudomembranous colitis with rectosigmoid sparing on barium studies. Radiology 1989, 170:811.
39. Boland GW, Lee MJ, Cats AM, et al.: Antibiotic-induced diarrhea: specificity of abdominal CT for the diagnosis of Clostridium difficile disease. Radiology 1994, 191:103.
40. Fishman E, Kavuru M, Kulzlman JE, et al.: CT of pseudomembranous colitis: Radiologic, clinical and pathologic correlation. Radiology 1991, 180:57.
41. Shahrabadi MS, Bryan LE, Gaffney D, et al.: Latex agglutination test for detection of Clostridium difficile toxin in stool samples. J Clin Microbiol 1984, 20:339.
42. Lyerly DM, Barroso, LA, Wilkins TD: Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol 1991, 29:2639.
43. Laughon BE, Viscidi RP, Gdovin St, et al.: Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens. J Infect Dis 1984, 149:781.
44. DiPersio JP, Varga FJ, Conwell DL, et al.: Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease. J Clin Microbiol 1991, 29:2724.
45. Merz CS, Kramer C, Forman M, et al.: Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens. J Clin Microbiol 1994, 32:1142.
46. Kurzynski TA: Evaluation of C. difficile CUBE test for detection of Clostridium difficile-associated diarrhea. Digan Microbiol Infect Dis 1992, 15:493.
47. Kato N, Ou C-Y, Kato H, et al.: Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 1991, 29:33-37.
48. Kuhl SJ, Tang YJ, Navarro L, et al.: Diagnosis and monitoring of Clostridium difficile infections with the polymerase chain reaction. Clin Infect Dis 1993, 16(suppl. 4):S234.
49. Arzese A, Trani G, Riul L, Botta GA: Rapid polymerase chain reaction method for specific detection of toxigenic Clostridium difficile. Eur J Clin Microbiol Infect Dis 1995, 14:716.
50. Bond F, Payne G, Borriello SP, Humphreys H: Usefulness of culture in the diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis 1995, 14:223.
51. Gerding DN, Johnson S, Peterson LR, et al.: Clostridium difficile-associated diarrhea and colitis. Infect Control Hosp Epidemiol 1995, 16:459.
52. Riley TV, Cooper M, Bell B, Golledge CL: Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis 1995, 20(suppl. 2):S263.
53. Tabaqchali S, O'Farrell S, Holland D, Silman R: Typing scheme for Clostridium difficile: Its application in clinical and epidemiological studies, Lancet 1984, i:935.
54. Clabots CR, Johnson S, Bettin KM, et al.: Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J Clin Micrbiol 1993, 31:1870.
55. Pantosti A, Cerquetti M, Gianfrilli PM: Electrophoretic characterization of Clostridium difficile strains isolated from antibiotic-associated colitis and other conditions. J Clin Microbiol 1988, 26:540.
56. Brazier JS: An international study on the unification of nomenclature for typing Clostridium difficile. Clin Infect Dis 1995, 20(suppl. 2):S325.
57. Bartlett JG: Treatment of Clostridium difficile colitis. Gastroenterology 1985, 89:1192.
58. Fekety R, Silva J, Armstrong J, et al.: Treatment of antibiotic-associated enterocolitis with vancomycin. Rev Infect Dis 1981, 3:S273.
59. Teasley DG, Olson MM, Gebhard RL, et al.: Prospective randomized trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet 1983, ii:1444.
60. Burdon DW, Brown JD, Youngs D, et al.: Antibiotic susceptibility of Clostridium difficile. J Antimicrob Chemother 1979, 5:307.
61. Dzink JA, Bartlett IG: In vitro susceptibility of Clostridium difficile isolates from patients with antibiotic-associated diarrhea or colitis. Antimicrob Agents Chemother 1980, 17:695.
62. Bartlett JG: Treatment of antibiotic-associated pseudomembranous colitis. Rev Infect Dis 1984, 6:S235.
63. Fekety R, Silva J, Kaufman C, et al Treatment of antibiotic-associated C. difficile colitis with oral vancomycin: comparison of two dosage regimens. Am J Med 1989, 86:15.
64. Centers for Disease Control: Recommendations for preventing the spread of vancomycin resistance. Morb Mort Weekly Rep 44 RR-12 1995, 1.
65. Young GP, Ward PB, Bayley N: Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. Gastroenterology 1985, 89:1038.
66. Tedesco FJ: Treatment of recurrent antibiotic-associated pseudomembranous colitis. Am J Gastroenterol 1982, 77:220.
67. Bowden TA, Mansberger AR, Lykins LE: Pseudomembranous enterocolitis: mechanism of restoring floral homeostasis. Am Surg 1981, 47:178.
68. Schwan A, Sjolin S, Trottestam U, et al.: Relapsing Clostridium difficile enterocolitis cured by rectal infusion of normal feces. Scand J Infect Dis 1984, 16:211.
69. Tvede M, Rask-Madsen J: Bacteriotherapy for chronic relapsing Clostridium difficile diarrhoea in six patients. Lancet 1989, 6i:1156.
70. Surawicz CM, Elmer GW, Speelman P, et al.: Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study. Gastroenterology 1989, 96:981.
71. Elmer GW, McFarland LV: Suppression by Saccharomyces boulardii of toxigenic Clostridium difficile overgrowth after vancomycin treatment in hamsters. Antimicrob Agents Chemother 1987, 31:129.
72. Gorbach S, Chang T-W, Goldin B: Successful treatment of relapsing C. difficile colitis with Lactobacillus GG. Lancet 1987, ii:1519.
73. Buggy BP, Fekely R, Silva J: Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 1987, 9:155.
74. Leung DY, Kelly CP, Boguniewicz M, et al.: Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxin. J Pediatr 1991, 118:633.
75. Hassett J, Meyers S, McFarland L, Mulligan ME: Recurrent Clostridium difficile infection in a patient with selective IgC1 deficiency treated with intravenous immune globulin and Saccharomyces boulardii. Clin Infect Dis 1995, 20(suppl. 2):S266.
76. Lipsett PA, Samantaray DK, Tam ML, et al.: Pseudomembranous colitis: a surgical disease? Surgery 1994, 116:491.
77. McFarland LV, Surawicz CM, Stamm WE: Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 1490, 162:678.
78. Simor AE, Yake SL, Tsimidis K: Infection due to Clostridium difficile among elderly residents of a long term care facility. Clin Infect Dis 1993, 17:672.
79. Fekety R, Kim KH, Brown D, et al.: Epidemiology of antibiotic-associated colitis. Am J Med 1981, 70:906.
80. Pear SM, Williamson TH, Bettin KM, et al.: Decrease in nosocomial Clostridium diffifcile-associated diarrhea by restricting clindamycin use. Ann Intern Med 1994, 120:272.
81. Gerding DN, Olson M, Peterson R, et al.: Clostridium difficile-associated diarrhea and colitis in adults. A prospective case controlled epidemiologic study. Arch Intern Med 1986, 146:95.
82. Kaatz GW, Gitlin SD, Schaberg DR, et al.: Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988, 127:1289.
83. Bender BS, Laughon BE, Gaydos G, et al.: Is Clostridium difficile endemic in chronic care facilities? Lancet 1986, ii:11.
84. Johnson S, Clabots CR, Linn FV, et al.: Nosocomial Clostridium difficile colonization and disease. Lancet 1990, 336:97.
85. Samore MH, DeGirolami PC, Tlucko A, et al.: Clostridium difficile colonization and diarrhea at a tertiary care hospital. Clin Infect Dis 1994, 18:181.
86. Samore MH, Venkataraman L, GeGirolami PC, et al.: Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996, 100:32.